Results 91 to 100 of about 51,672 (208)

Osteonecrose da mandíbula em paciente portador de mieloma múltiplo: patologia secundária ao uso do pamidronato Jaw osteonecrosis in a patient suffering from multiple myeloma: pathology secondary to pamidronate therapy

Revista Brasileira de Hematologia e Hemoterapia, 2005
Descreveremos a ocorrência de osteonecrose da mandíbula associada ao uso de pamidronato (Aredia ) em uma paciente portadora de mieloma múltiplo. Apesar de não ser possível provar definitivamente a associação entre a terapia com bisfosfonatos e a ...
Andréia C. Melo, Marcos Bastos, Maria R. Bastos, Adrieli S. Loureiro, Sérgio S. Araújo   +4 more
doaj   +1 more source

Osteochemonecrosis of the jaws due to bisphosphonate treatments : update [PDF]

, 2008
Bisphosphonates (BP),were initially used in industry and later as a drug due to their great affinity to osseous tissue, because of their powerful antiresorptive effect as a treatment in various osteopathies, such as osteoporosis, Paget disease or ...
Gómez Font, Rafael, Martínez García, María Luisa, Olmos Martínez, José Manuel   +2 more
core  

The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta

The Turkish Journal of Pediatrics, 2004
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology.
Pelin Adiyaman, Gönül Ocal, Merih Berberoğlu, Olcay Evliyaoğlu, Zehra Aycan, Ergun Cetinkaya   +5 more
doaj  

Literature Review of Using Bisphosphonates in the Treatment of Calciphylaxis

罕见病研究
Objective To analyze the effectiveness and safety of bisphosphonates in the treatment of patients with calcification defense. Methods PubMed, Embase databases, CNKI and Wanfang were searched to collect the case reports and clinical studies of ...
LIANG Chunsu, WANG Shaohong, ZHANG Yizhou, LIU Xin, NIU Ziran, SHI Yili, ZHANG Bo   +6 more
doaj   +1 more source

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel [PDF]

, 2017
Bisphosphonates (BP) prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such events since their introduction.
Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F., Thürlimann, B.   +18 more
core  

The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial

International Journal of Organ Transplantation Medicine, 2017
Background: Although bone grafts are commonly used in reconstructive surgeries, they are sensitive to local perfusion and are thus prone to severe resorption.
M Bayat, A Garajei, E Afshari Pour, M Hasheminasab, Y Ghorbani, MH Kalantar Motamedi, N Bahrami   +6 more
doaj  

Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy

Biomedical Papers
Chronic recurrent multifocal osteomyelitis (CRMO), also called chronic nonbacterial osteomyelitis (CNO) or nonbacterial osteomyelitis (NBO), is a rare autoinflammatory bone disease of unknown etiology.
Katerina Bouchalova, Zuzana Pytelova
doaj   +1 more source

Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial [PDF]

, 2017
Background: We report the first results of a randomized trial assessing a new oral aminobisphosphonate, ibandronate, in patients with bone metastases from breast cancer. Patients and methods: Patients (n = 435) received placebo, or oral ibandronate 20 mg
Apffelstaedt, J., Bergstrom, B., Budde, M., Lazarev, A., Lichinitzer, M., MacLachlan, S. A., Tripathy, D.   +6 more
core  

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

Therapeutics and Clinical Risk Management, 2008
Dimitrios Chantzichristos, Andréasson Björn, Johansson PeterDepartment of Internal Medicine, Uddevalla Hospital, Uddevalla, SwedenBackground: Once a month, patients with multiple myeloma received an infusion of bisphosphonates ...
Dimitrios Chantzichristos, Andréasson Björn, Johansson Peter   +2 more
doaj  

Collapsing glomerulopathy: A 30-year perspective and single, large center experience [PDF]

, 2017
Cossey, Nicholas, Larsen, Christopher P, Liapis, Helen   +2 more
core   +2 more sources